5 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
Below we present the list of 5 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.
Dice Therapeutics Inc. (DICE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Tudor Investment Corp Paul Tudor Jones | 0 | $0 | 0% | |
| 2. | RA Capital Management Peter Kolchinsky | 0 | $0 | 0% | |
| 3. | Pentwater Capital Management Matthew Halbower | 0 | $0 | 0% | |
| 4. | Braidwell LP Alex Karnal | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $28.74 | 195,997 | Large Shareholder, Director | 7,070,205 | 2023-03-30 | Filing | |
| $29.38 | 66,369 | Large Shareholder, Director | 6,874,208 | 2023-03-29 | Filing | |
| $29.24 | 246,779 | Large Shareholder, Director | 6,807,839 | 2023-03-28 | Filing | |
| $27.48 | 151,132 | Large Shareholder, Director | 6,561,060 | 2023-03-27 | Filing | |
| $26.87 | 192,335 | Large Shareholder, Director | 6,409,928 | 2023-03-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $46.50 | 523,503 | Large Shareholder | 166,293 | 2023-06-22 | Filing | |
| $46.50 | 1,969,368 | Large Shareholder | 633,707 | 2023-06-22 | Filing | |
| $31.24 | 4,443 | Officer | 147,497 | 2023-06-01 | Filing | |
| $30.31 | 14,307 | Officer | 151,940 | 2023-06-01 | Filing | |
| $38.51 | 84,097 | Director | 8,427 | 2023-05-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Top 5 Stocks Activist Investors Are Targeting
Next in line in our list of top 10 stocks activist investors are targeting is another healthcare company in which RA Capital increased its position.
Here’s Why Meridian Small Cap Growth Fund Trimmed DICE Therapeutics (DICE)
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Small Cap Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
Hedge Fund and Insider Trading News: Altimeter Capital, Third Point LLC, Bridgewater Associates, Schonfeld Strategic Advisors, Brevan Howard Asset Management, Nordic Cross Asset Management, Lockheed Martin Corporation (LMT), DICE Therapeutics, Inc. (DICE), and More
Bridgewater Associates, one of the world’s biggest hedge funds, hired Yuriy Podoshev to boost its engineering team.
Hedge Fund and Insider Trading News: Ken Griffin, Jim Chanos, Schroders, Edge Capital Management, Starboard Value LP, Wincrest Capital, German American Bancorp., Inc. (GABC), DICE Therapeutics, Inc. (DICE), and More
Republicans are seeking to regain control of Illinois’s highest court for the first time in more than 50 years, with decisions on abortion access and workers’ rights on the line.
15 Pharmaceutical Stocks to Buy According to Peter Kolchinsky's RA Capital
In this piece, we will take a look at the top 15 pharmaceutical stocks to buy according to Peter Kolchinsky's RA Capital.
Billionaire Hedge Funds
